We invest in the “business” of healthcare rather than the “science” in order to pursue investments that often require less capital, are more scalable, have fewer regulatory hurdles and are capable of generating recurring revenue. We specifically target companies that are able to leverage existing distribution channels in order to more efficiently and cost-effectively get to market. - See more at: http://texoventures.com/about/#sthash.xLqcDi9S.dpuf
People
- Philip Sanger, Managing Partner
You last contacted this investor on .